BMSN - Bio-Matrix Scientific Group, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue100192-
Cost of Revenue---
Gross Profit100192-
Operating Expenses
Research Development671.093282.29523.867
Selling General and Administrative2,555.072,076.094845.448
Non Recurring---
Total Operating Expenses---
Operating Income or Loss-3,126.163-2,166.389-869.315
Income from Continuing Operations
Total Other Income/Expenses Net-5,103.44-51,717.06-1,176.507
Earnings Before Interest and Taxes-8,229.603-53,883.449-2,045.822
Interest Expense227.151206.86935.136
Income Before Tax-8,456.754-54,090.318-2,080.958
Income Tax Expense---
Minority Interest447.89382.0520.017
Net Income From Continuing Ops-1,684.407-45,112.585-1,854.724
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-1,684.407-45,112.585-1,854.724
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-1,684.406-45,112.586-1,854.724